Bladder cancer showdown: can radiation and chemotherapy match surgery?
NCT ID NCT07008833
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for muscle-invasive bladder cancer: radiation combined with chemotherapy versus surgery to remove the bladder. About 336 adults with this cancer will be randomly assigned to one of the two groups. The goal is to see if the non-surgical approach works as well as surgery at preventing the cancer from spreading.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brazilian Clinical Research Institute
São Paulo, São Paulo, 01404100, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Bladder cancer: a new combo aims to avoid radical surgery
- Can a special PET scan see bladder cancer more clearly?
- Bladder cancer surgery: what happens after the bladder is removed?
- Lab-Grown tumor clusters guide tailored bladder cancer therapy
- Experimental immunotherapy targets tough urinary cancers